
Xenon Pharmaceuticals is a biotechnology business based in the US. Xenon Pharmaceuticals shares (XENE) are listed on the NASDAQ and all prices are listed in US Dollars. Xenon Pharmaceuticals employs 149 staff and has a trailing 12-month revenue of around $13.2 million.
How to buy Xenon Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – XENE. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
eToro
- Easy to use platform with low fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Xenon Pharmaceuticals stock price (NASDAQ: XENE)
Use our graph to track the performance of XENE stocks over time.Xenon Pharmaceuticals shares at a glance
Latest market close | $39.19 |
---|---|
52-week range | $24.94 - $41.39 |
50-day moving average | $37.28 |
200-day moving average | $34.57 |
Wall St. target price | $50.67 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.56 |
Buy Xenon Pharmaceuticals stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Xenon Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Xenon Pharmaceuticals price performance over time
Historical closes compared with the close of $39.19 from 2023-02-03
1 week (2023-01-31) | 0.26% |
---|---|
1 month (2023-01-06) | 2.43% |
3 months (2022-11-07) | 12.71% |
6 months (2022-08-05) | 1.87% |
1 year (2022-02-03) | N/A |
---|---|
2 years (2021-02-05) | 142.81% |
3 years (2020-02-07) | 166.06% |
5 years (2018-02-07) | 1,061.19% |
Xenon Pharmaceuticals financials
Revenue TTM | $13.2 million |
---|---|
Gross profit TTM | $-57,026,000 |
Return on assets TTM | -13.3% |
Return on equity TTM | -22.66% |
Profit margin | 0% |
Book value | $12.04 |
Market capitalisation | $2.4 billion |
TTM: trailing 12 months
Xenon Pharmaceuticals share dividends
We're not expecting Xenon Pharmaceuticals to pay a dividend over the next 12 months.
Xenon Pharmaceuticals share price volatility
Over the last 12 months, Xenon Pharmaceuticals's shares have ranged in value from as little as $24.94 up to $41.39. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Xenon Pharmaceuticals's is 1.3634. This would suggest that Xenon Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Xenon Pharmaceuticals overview
Xenon Pharmaceuticals Inc. , a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1. 6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other potential indications, including adult focal epilepsy; and XEN007, A central nervous system-acting calcium channel modulator, which is in Phase II clinical trials. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy; and with Flexion Therapeutics, Inc.
Xenon Pharmaceuticals in the news
Investors in Xenon Pharmaceuticals (NASDAQ:XENE) have made a fantastic return of 965% over the past five years
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2023
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2023
Frequently asked questions
What percentage of Xenon Pharmaceuticals is owned by insiders or institutions?Currently 1.705% of Xenon Pharmaceuticals shares are held by insiders and 95.769% by institutions. How many people work for Xenon Pharmaceuticals?
Latest data suggests 149 work at Xenon Pharmaceuticals. When does the fiscal year end for Xenon Pharmaceuticals?
Xenon Pharmaceuticals's fiscal year ends in December. Where is Xenon Pharmaceuticals based?
Xenon Pharmaceuticals's address is: 3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8 What is Xenon Pharmaceuticals's ISIN number?
Xenon Pharmaceuticals's international securities identification number is: CA98420N1050 What is Xenon Pharmaceuticals's CUSIP number?
Xenon Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 98420N105
More guides on Finder
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert